Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ina03 (1 trial)
Acute Disease (Phase 1)
Leukemia (Phase 1)
Leukemia, Lymphoid (Phase 1)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)
Recurrence (Phase 1)
Trials (1 total)
Trial APIs (1 total)